Paulo S Pinheiro1, Heidy N Medina2, Karen E Callahan3, Tulay Koru-Sengul4, Janaki Sharma5, Erin N Kobetz6, Frank J Penedo7. 1. Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, USA; Public Health Sciences, University of Miami School of Medicine, USA. Electronic address: pxp464@med.miami.edu. 2. Public Health Sciences, University of Miami School of Medicine, USA. Electronic address: h.medina3@umiami.edu. 3. School of Public Health, University of Nevada Las Vegas, USA. Electronic address: karen.callahan@unlv.edu. 4. Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, USA; Public Health Sciences, University of Miami School of Medicine, USA. Electronic address: tsengul@med.miami.edu. 5. Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, USA. Electronic address: jsharma@miami.edu. 6. Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, USA; Public Health Sciences, University of Miami School of Medicine, USA. Electronic address: ekobetz@med.miami.edu. 7. Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, USA; Department of Psychology, University of Miami, USA. Electronic address: fpenedo@miami.edu.
Abstract
INTRODUCTION: Kidney cancer incidence is increasing among Hispanics but rate differences by distinct group, such as Cuban, Puerto Rican, and Mexican have not been studied. To fill this knowledge gap, we use mortality data, reflecting fatal kidney cancers, to examine patterns by race-ethnicity, including detailed Hispanic groups, and correlate the mortality rates with each group's prevalence of known kidney cancer risk factors: smoking, obesity, hypertension, diabetes, and chronic kidney disease. METHODS: We used individual-level death data for California, Florida, and New York (2008-2018), and population prevalence data from the National Health Interview Surveys (2008-2018). Age-adjusted mortality rates (AAMRs) and regression-derived mortality rate ratios (MRRs) were computed. Pearson correlation analyses assessed the extent to which group-specific risk factor prevalence explained variability in observed AAMRs. RESULTS: US-born Mexican Americans and American Indians had the highest rates and MRRs compared to Whites: 1.44 (95 %CI: 1.35-1.53) and 1.51 (1.38-1.64) for Mexican American men and women, respectively, and 1.54 (95 %CI: 1.25-1.89) and 1.53 (95 %CI: 1.15-2.04) for American Indians. In contrast, non-Mexican Hispanics had lower rates than Whites. Among males, positive correlations between AAMRs and smoking, obesity, and chronic kidney disease prevalence by race-ethnicity were found. CONCLUSION: Mexican Americans and American Indians are high-risk for fatal kidney cancer. Disparities are only partially attributable to higher smoking and obesity prevalence, and more so among men than women. A shared risk factor profile, as well as possible genetic similarities, may explain their disproportionately higher kidney cancer mortality, but further research is warranted.
INTRODUCTION: Kidney cancer incidence is increasing among Hispanics but rate differences by distinct group, such as Cuban, Puerto Rican, and Mexican have not been studied. To fill this knowledge gap, we use mortality data, reflecting fatal kidney cancers, to examine patterns by race-ethnicity, including detailed Hispanic groups, and correlate the mortality rates with each group's prevalence of known kidney cancer risk factors: smoking, obesity, hypertension, diabetes, and chronic kidney disease. METHODS: We used individual-level death data for California, Florida, and New York (2008-2018), and population prevalence data from the National Health Interview Surveys (2008-2018). Age-adjusted mortality rates (AAMRs) and regression-derived mortality rate ratios (MRRs) were computed. Pearson correlation analyses assessed the extent to which group-specific risk factor prevalence explained variability in observed AAMRs. RESULTS: US-born Mexican Americans and American Indians had the highest rates and MRRs compared to Whites: 1.44 (95 %CI: 1.35-1.53) and 1.51 (1.38-1.64) for Mexican American men and women, respectively, and 1.54 (95 %CI: 1.25-1.89) and 1.53 (95 %CI: 1.15-2.04) for American Indians. In contrast, non-Mexican Hispanics had lower rates than Whites. Among males, positive correlations between AAMRs and smoking, obesity, and chronic kidney disease prevalence by race-ethnicity were found. CONCLUSION: Mexican Americans and American Indians are high-risk for fatal kidney cancer. Disparities are only partially attributable to higher smoking and obesity prevalence, and more so among men than women. A shared risk factor profile, as well as possible genetic similarities, may explain their disproportionately higher kidney cancer mortality, but further research is warranted.
Authors: Alejandro Sanchez; Helena Furberg; Fengshen Kuo; Lynda Vuong; Yasser Ged; Sujata Patil; Irina Ostrovnaya; Stacey Petruzella; Albert Reising; Parul Patel; Roy Mano; Jonathan Coleman; Paul Russo; Catherine H Liu; Andrew J Dannenberg; Timothy A Chan; Robert Motzer; Martin H Voss; A Ari Hakimi Journal: Lancet Oncol Date: 2019-12-20 Impact factor: 41.316
Authors: Steffen Weikert; Heiner Boeing; Tobias Pischon; Cornelia Weikert; Anja Olsen; Anne Tjonneland; Kim Overvad; Nikolaus Becker; Jakob Linseisen; Antonia Trichopoulou; Theodore Mountokalakis; Dimitrios Trichopoulos; Sabina Sieri; Domenico Palli; Paolo Vineis; Salvatore Panico; Petra H M Peeters; H Bas Bueno-de-Mesquita; W M Monique Verschuren; Borje Ljungberg; Goran Hallmans; Goran Berglund; Carlos A González; Miren Dorronsoro; Aurelio Barricarte; M J Tormo; Naomi Allen; Andrew Roddam; Sheila Bingham; Kay-Tee Khaw; Sabina Rinaldi; Pietro Ferrari; Teresa Norat; Elio Riboli Journal: Am J Epidemiol Date: 2007-11-29 Impact factor: 4.897
Authors: Andrew F Olshan; Tzy-Mey Kuo; Anne-Marie Meyer; Matthew E Nielsen; Mark P Purdue; W Kimryn Rathmell Journal: Cancer Med Date: 2013-08-06 Impact factor: 4.452
Authors: Paulo S Pinheiro; Karen E Callahan; Scarlett Lin Gomez; Rafael Marcos-Gragera; Taylor R Cobb; Aina Roca-Barcelo; Amelie G Ramirez Journal: BMC Cancer Date: 2017-07-11 Impact factor: 4.430
Authors: Elizabeth M Ward; Recinda L Sherman; S Jane Henley; Ahmedin Jemal; David A Siegel; Eric J Feuer; Albert U Firth; Betsy A Kohler; Susan Scott; Jiemin Ma; Robert N Anderson; Vicki Benard; Kathleen A Cronin Journal: J Natl Cancer Inst Date: 2019-12-01 Impact factor: 13.506
Authors: Stephanie C Melkonian; Hannah K Weir; Melissa A Jim; Bailey Preikschat; Donald Haverkamp; Mary C White Journal: Am J Epidemiol Date: 2021-04-06 Impact factor: 4.897
Authors: Ken Batai; Alfredo Harb-De la Rosa; Jiping Zeng; Juan J Chipollini; Francine C Gachupin; Benjamin R Lee Journal: Cancer Med Date: 2019-09-11 Impact factor: 4.452
Authors: Claudia Santucci; Heidy N Medina; Greta Carioli; Eva Negri; Carlo La Vecchia; Paulo S Pinheiro Journal: Eur J Cancer Prev Date: 2021-08-26 Impact factor: 2.164
Authors: Alejandro Cruz; Faith Dickerson; Kathryn R Pulling; Kyle Garcia; Francine C Gachupin; Chiu-Hsieh Hsu; Juan Chipollini; Benjamin R Lee; Ken Batai Journal: Int J Environ Res Public Health Date: 2022-02-12 Impact factor: 3.390
Authors: Francine C Gachupin; Benjamin R Lee; Juan Chipollini; Kathryn R Pulling; Alejandro Cruz; Ava C Wong; Celina I Valencia; Chiu-Hsieh Hsu; Ken Batai Journal: Int J Environ Res Public Health Date: 2022-01-21 Impact factor: 3.390